Ocular Gene Therapy


Ocular gene therapy has made a rapid progress in the past few years. This method directly administered into the eye, targeting diseases caused by mutations in the gene RPE65. Mutations in ths gene can produce Retinitis Pigmentosa, a rare but potentially Blinding diseases.


  • Gene replacement
  • DNA Nanoparticle
  • RNA Interference
  • Ex vivo for Retinal Pigmentosa

Related Conference of Ocular Gene Therapy

February 18-19, 2022

32nd World Congress on Ophthalmology and Optometry

Rome, Italy
March 07-08, 2022

7th Global Pediatric Ophthalmology Congress

Barcelona, Spain
March 21-22, 2022

22nd Global Ophthalmologists Annual meeting

Amsterdam, Netherlands
April 11-12, 2022

2nd International Conference on Ophthalmology

Prague, Czech Republic
April 21-22, 2022

5th International Conference on Ear Nose and Throat

Amsterdam, Netherlands
April 26-27, 2022

European Conference on Ophthalmology & Eye care

Auckland, Newzealand
April 27-28, 2022

6th World Congress on Ophthalmology and Vision Science

Toronto, Canada
April 28-29, 2022

3rd International Conference on Optometry

Amsterdam, Netherlands
May 04-05, 2022

9th Global Ophthalmology Meeting

Prague, Czech Republic
August 01-02, 2022

World Congress on Ophthalmology and Optometry

Rome, Aland Islands
September 26-27, 2022

32nd International Congress on Vision Science and Eye

Rome, Italy
October 10-11, 2022

36th European Ophthalmology Congress

Vienna, Austria

Ocular Gene Therapy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in